Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 2/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3135862 | 0.87 | STAT3 (0.52) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL10593812 | 0.87 | STAT3 (0.44) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL7794014 | 0.86 | STAT3 (0.51) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL10592620 | 0.85 | ALDH1A1 (0.43) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL10458162 | 0.85 | STAT3 (0.54) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL34472509 | 0.84 | STAT3 (0.50) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL2103375 | 0.84 | POLB (0.43) | STAT3ALDH1A1 | |
| SCHEMBL4727494 | 0.84 | STAT3 (0.56) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL12566164 | 0.83 | TBXA2R (0.41) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 | |
| SCHEMBL11272932 | 0.83 | STAT3 (0.49) | STAT3CTDSP1SIRT5ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7001973-B2 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2006-02-21 | — | — | US | claimed |
| EP-0881205-A1 | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1998-12-02 | — | — | EP | claimed |
| US-5633411-A | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1997-05-27 | — | — | US | claimed |
| EP-3275855-B1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHINETSU CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10138189-B2 | Methods for producing 2,6-dimethyl-1,5-heptadien-3-ol and 2,6-dimethyl-1,5-heptadien-3-yl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-11-27 | — | — | US | disclosed |
| US-20180029964-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3275855-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-01-31 | — | — | EP | disclosed |
| US-7001973-B2 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2006-02-21 | — | — | US | disclosed |
| US-20030187178-A1 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2003-10-02 | — | — | US | disclosed |
| US-6613863-B2 | Benzyltrialkylammonium carboxylate isocyanate trimerization catalysts | DEGUSSA AG (DE) | 2003-09-02 | — | — | US | disclosed |
| US-20020120089-A1 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2002-08-29 | — | — | US | disclosed |
| US-5633411-A | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0602254-B1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KK (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5476913-A | Bactericides | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1995-12-19 | — | — | US | disclosed |
| EP-0602254-A1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1994-06-22 | — | — | EP | disclosed |
| EP-0101877-B1 | PROCESS FOR THE PREPARATION OF N-ALLYL-O-ALKYL-THIONCARBAMATES | AMERICAN CYANAMID COMPANY (US) | 1986-11-26 | — | — | EP | disclosed |
| US-4482500-A | Process for the preparation of N-allyl-O-alkyl thionocarbamates | AMERICAN CYANAMID COMPANY (US) | 1984-11-13 | — | — | US | disclosed |
| US-4479903-A | Process for the preparation of N-allyl-O-alkyl thionocarbamates | AMERICAN CYANAMID COMPANY (US) | 1984-10-30 | — | — | US | disclosed |
| EP-0101877-A1 | Process for the preparation of N-allyl-o-alkyl-thioncarbamates | AMERICAN CYANAMID COMPANY (US) | 1984-03-07 | — | — | EP | disclosed |
| US-4016193-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JA) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180029964-A1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | MSMO1, CYP8B1, ACMSD | STAT3 4292/4885CTDSP1 3937/4885SIRT5 1028/4885 |
| US-10138189-B2 | Methods for producing 2,6-dimethyl-1,5-heptadien-3-ol and 2,6-dimethyl-1,5-heptadien-3-yl acetate | MSMO1, CYP8B1, ACMSD | STAT3 4292/4885CTDSP1 3937/4885SIRT5 1028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.